By Jeremy Loffredo
On Tuesday, AstraZeneca announced a pause on its experimental COVID-19 vaccine trial after a woman in the UK developed a “suspected serious reaction.” The company is also conducting trials in the U.S., South Africa and Brazil, with enrollment in all these countries on hold for now.
AstraZeneca is partnering with researchers at Oxford University to develop this vaccine, and is testing it on children as young as 5 years old…
